J06BB02 • tetanus immunoglobulin • Antiinfectives for systemic use | Immunoglobulins | Specific immunoglobulins
Tetanus immunoglobulin is a plasma-derived product used to prevent tetanus in individuals exposed to Clostridium tetani bacteria, usually through contaminated wounds. It provides passive immunity by supplying pre-formed antibodies against the tetanus toxin.
The medication is administered via intramuscular injection, as directed by a doctor.
Side effects may include pain at the injection site, fever, or allergic reactions. In rare cases, anaphylactic reactions may occur.
Patients should inform their doctor about any known allergies or other medications they are taking. Pregnant or breastfeeding women should consult a specialist before use.
Substance: tetanus immunoglobulin
Date of last drug list: 01-07-2013
Commercial code: W13354001
Concentration: 250UI / ml
Pharmaceutical form: solution for intramuscular injection
Quantity: 1
Product type: generic
Prescription restrictions: S - Medicines prescription reserved for use in certain specialized fields.